Methebac

Composition

Methebac Tablet: Each tablet contains Methenamine Hippurate USP 1 g.

Indications

Methebac is indicated for prophylactic or suppressive treatment of frequently recurring urinary tract infections when long-term therapy is considered necessary. This drug should only be used after eradication of the infection by other appropriate antimicrobial agents.

Dosage & Administration

1 tablet (1.0 g) twice daily (morning and night) for adults and paediatric patients over 12 years of age. 1/2 to 1 tablet (0.5 to 1.0 g) twice daily (morning and night) for paediatric patients 6 to 12 years of age. Since the antibacterial activity of Methebac is greater in acid urine, restriction of alkalinizing foods and medications is desirable or as directed by the physician.

Malifa

Composition:

Malifa 30: Each capsule contains Ferric Maltol INN equivalent to Iron 30 mg.

Indication:
It is indicated for the treatment of iron deficiency in adults.

Dosage & Administration

• 30 mg twice daily on an empty stomach (Morning & Evening).

• Continue as long as necessary to replenish body iron stores

  or as directed by the physician.

Momespray

Composition:

Momespray™: Each spray contains Mometasone Furoate BP 50 meg.

Indication:

Momespray™ is indicated for the treatment of the nasal symptoms of seasonal and perennial allergic rhinitis, in adults and pediatric patients 2 years of age and older. It

is indicated for the prophylaxis of the nasal symptoms of seasonal allergic rhinitis in adult and adolescent patients 12 years and older. It is also indicated for the treatment of

nasal polyps in patients 18 years and older.

Dose & Administration:

Administer Mometasone Nasal Spray by the intranasal route only.

Allergic Rhinitis

Adults and Children 12 Years of Age and Older: For prophylaxis and treatment of the nasal symptoms of seasonal allergic rhinitis and treatment of the nasal

symptoms of perennial allergic rhinitis use two sprays (50 meg of Mometasone Furoate in each spray) in each nostril once daily (total daily dose of 100 meg). In patients

with a known seasonal allergen that precipitates nasal symptoms of seasonal allergic rhinitis, prophylaxis use Momespray™ 50 meg (200 meg/day) 2 to 4 weeks prior

to the anticipated start of the pollen season.

Children (2 to 11 years of age) For treatment of the nasal symptoms of seasonal and perennial allergic rhinitis use one spray (50 meg of Mometasone Furoate in each spray) in each nostril once daily (total daily dose of 100 meg).

Nasal Polyps

Adults 18 years of Age and Older: For nasal polyps use two sprays (50 meg of Mometasone Furoate in each spray) in each nostril twice daily (total daily dose of 400

meg). A dose of two sprays (50 meg of mometasone furoate in each spray) in each nostril once daily (total daily dose of 200 meg) is also effective in some patients.

Meltix